HIGHLIGHTS
- who: Amir Bahador Boroumand and collaborators from the INSERM , Institut Cochin, France Osaka University, Japan have published the Article: Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review, in the Journal: (JOURNAL) of April/27,/2022
- what: Most of this studies indicate lower antibody response in patients with DM compared to individuals without DM after the second dose of vaccine and irrespective of vaccine Several studies have shown that higher age and higher BMI are associated with lower antibody response while optimum glycemic control and higher GFR are associated with higher . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.